Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion [1]

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 4, 2006, Pages 555-556

  Spandau, Ulrich H M ^a,b   Ihloff, Anna K ^a   Jonas, Jost B ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETATE; VASCULOTROPIN;

AGED; CASE REPORT; CATARACT; CENTRAL RETINA VEIN OCCLUSION; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFICACY; FOLLOW UP; HOMEOSTASIS; HUMAN; INFORMED CONSENT; INTRAOCULAR PRESSURE ABNORMALITY; LETTER; MALE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA ISCHEMIA; RETINA MACULA EDEMA; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33746358546     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2006.00740.x     Document Type: Letter

References (4)

1. Hayreh SS (1983): Classification of central retinal vein occlusion. Ophthalmology 83: 458-474.
2. Iturralde D, Spaide RF, Meyerle CB et al. (2006): Intravitreal bevacizumab (avastin) treatment of macular oedema in central retinal vein occlusion: A short-term study. Retina 26: 279-284.
3. Rosenfeld PJ, Fung AE & Puliafito CA (2005a): Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular oedema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36: 336-339.
4. Rosenfeld PJ, Moshfeghi AA & Puliafito CA (2005b): Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36: 331-335.